Literature DB >> 15566060

Medical management of severe traumatic brain injury.

Daniel Martin1, Martin Smith.   

Abstract

This article reviews the current guidelines for the management of patients with severe traumatic brain injury from presentation in the accident and emergency department, through transfer, to specialist treatment in a neurocritical care unit.

Entities:  

Mesh：

Year:  2004        PMID： 15566060     DOI： 10.12968/hosp.2004.65.11.17047

Source DB:  PubMed          Journal:  Hosp Med        ISSN： 1462-3935


  2 in total

1.  Xenon improves neurologic outcome and reduces secondary injury following trauma in an in vivo model of traumatic brain injury.

Authors:  Rita Campos-Pires; Scott P Armstrong; Anne Sebastiani; Clara Luh; Marco Gruss; Konstantin Radyushkin; Tobias Hirnet; Christian Werner; Kristin Engelhard; Nicholas P Franks; Serge C Thal; Robert Dickinson
Journal:  Crit Care Med       Date:  2015-01       Impact factor: 7.598

2.  Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in mice.

Authors:  Rita Campos-Pires; Tobias Hirnet; Flavia Valeo; Bee Eng Ong; Konstantin Radyushkin; Jitka Aldhoun; Joanna Saville; Christopher J Edge; Nicholas P Franks; Serge C Thal; Robert Dickinson
Journal:  Br J Anaesth       Date:  2019-05-21       Impact factor: 9.166
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.